Pulmonary Mucormycosis in a Patient with Crohn Disease on Immunosuppressive Medications including Infliximab

Pulmonary Mucormycosis in a Patient with Crohn Disease on Immunosuppressive Medications including Infliximab

Saved in:

Bibliographic Details
Main Authors:	Alissa J Wright, Theodore Steiner, Ana Maria Bilawich, John C English, C Frank Ryan
Format:	Article
Language:	English
Published:	Wiley 2013-01-01
Series:	Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:	http://dx.doi.org/10.1155/2013/363250
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Infliximab for Crohn's Disease: More Questions than Answers
by: Hugh James Freeman
Published: (2001-01-01)

Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
by: Neeraj Narula, et al.
Published: (2009-01-01)

Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease
by: Remo Panaccione, et al.
Published: (2004-01-01)

Crohn's Disease Associated with Sweet's Syndrome and Sjögren's Syndrome Treated with Infliximab
by: Erina N. Foster, et al.
Published: (2005-01-01)

Refractory Crohn’s Disease of the Vulva Treated with Infliximab: A Case Report
by: Sapna Makhija, et al.
Published: (2007-01-01)

Response to Infliximab in Crohn’s Disease: Genetic Analysis Supporting Expression Profile
by: Luz María Medrano, et al.
Published: (2015-01-01)

Funding the New Biologics – CCOHTA Report on the Cost Effectiveness of Infliximab for Crohn’s Disease: Pearls and Pitfalls
by: John K Marshall
Published: (2002-01-01)

Infliximab Combined with Enteral Nutrition for Managing Crohn’s Disease Complicated with Intestinal Fistulas
by: Xiao-Li Wu, et al.
Published: (2016-01-01)

Exclusive Enteral Nutrition versus Infliximab in Inducing Therapy of Pediatric Crohn’s Disease
by: Youyou Luo, et al.
Published: (2017-01-01)

Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease
Published: (2001-01-01)

Improvement of Lumbar Bone Mass after Infliximab Therapy in Crohn’s Disease Patients
by: Marina Mauro, et al.
Published: (2007-01-01)

Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy
by: Dustin E Loomes, et al.
Published: (2011-01-01)

Pulmonary Embolism following Cessation of Infliximab for Treatment of Miliary Tuberculosis
by: Brian Lee, et al.
Published: (2014-01-01)

Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
by: Hesham M. El Mazar, et al.
Published: (2025-01-01)

Funding the New Biologics – A Health Economic Critique of the CCOHTA Report: Infliximab for the Treatment of Crohn’s Disease
by: Craig R Mitton
Published: (2002-01-01)

Outcomes of Pediatric Patients with Crohn’s Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission
by: Yao Lv, et al.
Published: (2022-01-01)

Antitumor Necrosis Factor-Alpha (TNF-α) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn’s Disease
by: Ashley Fonseca, et al.
Published: (2021-01-01)

Clinical Features and Outcome of Mucormycosis
by: Carlos Rodrigo Camara-Lemarroy, et al.
Published: (2014-01-01)

Pulmonary Mucormycosis: A Case Report of a Rare Infection with Potential Diagnostic Problems
by: Salwa O. Mekki, et al.
Published: (2020-01-01)

Removal of bilobar abscesses complicated by pulmonary mucormycosis through a rigid bronchoscopic intervention
by: Jilei Cao, et al.
Published: (2025-02-01)

Metastatic Hepatocellular Carcinoma in a Patient with Crohn’s Disease Treated with Azathioprine and Infliximab: A Case Report and Literature Review
by: Kyle J. Fortinsky, et al.
Published: (2014-01-01)

Disseminated Chickenpox Following Live Varicella Vaccination in a Crohn’s Disease Patient on Combination Immunosuppression
by: Quintin Solano, et al.
Published: (2025-01-01)

Long Term Safety of Infliximab
by: Thomas F Schaible
Published: (2000-01-01)

Response of Fibroblastic Rheumatism to Infliximab
by: Ricardo Romiti, et al.
Published: (2009-01-01)

Sinonasal mucormycosis with an unusual involvement of palate
by: Santosh Kumar Swain
Published: (2022-01-01)

Infliximab Induces Increase in Triglyceride Levels in Psoriatic Arthritis Patients
by: Karla R. Castro, et al.
Published: (2011-01-01)

Pulmonary Mucormycosis – An Experience from a Tertiary Care Center in Southern India: A PULM MUCOR Study
by: Ashwin Oliver Arul, et al.
Published: (2025-01-01)

Rhino-Orbito-Cerebral Mucormycosis: Two Cases with Amaurosis as Presentation, Medical Surgical Management and Follow-Up
by: Carmen Navarro-Perea, et al.
Published: (2019-01-01)

The Safety of Infliximab Infusions in the Community Setting
by: James Ducharme, et al.
Published: (2010-01-01)

Renal Mucormycosis: A Rare and Potentially Lethal Complication of Kidney Transplantation
by: SreyRam Kuy, et al.
Published: (2013-01-01)

Maxillary mucormycosis masquerading as an endodontic-periodontal lesion
by: Abubacker Afreen Jannath, et al.
Published: (2024-07-01)

COVID-19 and Mucormycosis Coinfection: How Challenging It Is
by: Niranjan Nayak, et al.
Published: (2022-01-01)

Gastrointestinal Mucormycosis in a Renal Transplant Patient
by: Jill Tinmouth, et al.
Published: (2001-01-01)

Medical Therapy of Steroid-Resistant Crohn's Disease
by: Bruce E Sands
Published: (2000-01-01)

The Successful Use of Infliximab in a Relapsing Case of Susac’s Syndrome
by: Suran L. Fernando, et al.
Published: (2020-01-01)

All That Bleeds Is Not Infliximab-Refractory Ulcerative Colitis
by: JK Law, et al.
Published: (2009-01-01)

Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis
by: Remo Panaccione, et al.
Published: (2008-01-01)

Multimodal Surgical and Medical Treatment for Extensive Rhinocerebral Mucormycosis in an Elderly Diabetic Patient: A Case Report and Literature Review
by: Paola Di Carlo, et al.
Published: (2014-01-01)

A rare miscreant in a case of sinonasal mucormycosis
by: Neha Sharad, et al.
Published: (2024-04-01)

Clinical characteristics and prognosis of patients treated as invasive pulmonary aspergillosis outside of severe immunosuppression
by: Furui Liu, et al.
Published: (2025-01-01)